Breaking News, Financial News

Financial Report: Charles River Laboratories

Foreign exchange impacts sales

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories
 
2Q Revenues: $284.7 million (-1%)

2Q Earnings: $30.6 million (-6%)

YTD Revenues: $570.7 million (flat)

YTD Earnings: $57.1 million (-11%)

Comments: Research Models and Services sales were $173.6 million in quarter (-3%). Foreign exchange impacted sales by 3.8%. Preclinical Services sales were $111.1 million (+1%). Foreign currency exchange reduced sales by 2.1%.
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters